PI3Kalpha-IN-26 (Compound 11e) is a PI3Kalpha inhibitor with an IC50 of 75.31 nM. PI3Kalpha-IN-26 has a broad-spectrum anticancer activity, such as leukemia, colon and breast cancer, without significant cytotoxic effect on the normal Vero cells (mean IC50s of 2.74, 3.50, 3.34 and 85.29 µM, respectively)[1].
Molekulargewicht:
498.02
Formel:
C24H20ClN3O3S2
Target-Kategorie:
CDK,PI3K
Anwendungsbeschreibung:
MCE Product type: Reference compound1
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
